Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors.
about
Circulating glioma biomarkersThe evidence of glioblastoma heterogeneity.Combinatorial approaches for the identification of brain drug delivery targets.Therapeutic strategies for inhibiting invasion in glioblastoma.Serum proteomics of glioma: methods and applications.Interstitial guidance of cancer invasion.Polysialic acid is associated with better prognosis and IDH1-mutation in diffusely infiltrating astrocytomas.HNK-1 glycan functions as a tumor suppressor for astrocytic tumor.Circulating biomarkers of CNS tumors: an update.Systematic review of protein biomarkers of invasive behavior in glioblastoma.Towards developing biomarkers for glioblastoma multiforme: a proteomics view.Liquid biopsies in patients with diffuse glioma.Emerging circulating biomarkers in glioblastoma: promises and challenges.Moschamine inhibits proliferation of glioblastoma cells via cell cycle arrest and apoptosis.Clinicopathologic features of intracranial central neurocytomas in 2 dogs.Neural cell adhesion molecule isoform 140 declines with rise of WHO grade in human gliomas and serves as indicator for the invasion zone of multiform glioblastomas and brain metastases.Serum GFAP autoantibody as an ELISA-detectable glioma marker.Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.
P2860
Q26830329-0C234D96-8B7C-42DF-BE68-6E2FD578624CQ30300892-B64AD0D5-94E8-4026-A1B9-3C9403D0C6E3Q31119779-2A359789-4290-4D13-8513-8E2DF68FCD8CQ33426563-6E9A7911-ACE8-40FD-9E3E-23CBA60C5A25Q33509599-081CB248-4D81-46ED-AA62-6CED14189DFEQ34029050-ECC4285C-252E-44D9-85E4-97F47112BAFBQ34169068-1CC201B6-C126-4001-A6CB-F73C56D33455Q35213489-DB5F8D31-FF1F-4CF9-A006-455DED99562BQ38095109-8F9802D4-5D68-40D1-9155-2DF37D7F2182Q38165795-CB2E97A5-A443-4249-BA99-1453060BC0BCQ38239173-24D5DAE8-FBE6-48ED-AEC9-4FEEEA8C4E9DQ38365590-988923F9-6411-4C3F-A51D-05F8F201C53EQ38591062-E90ECE38-A6BA-435B-B1F1-B6C36FCBAC0EQ38704729-87ADD10A-D92C-4279-8484-C05CD0130B8FQ44972158-8C8F72EE-0119-4F95-A65E-83F6AE55F046Q48213748-8588E826-EB35-4DE8-B6B7-01743D11E064Q51066755-4D31D499-352D-4DF4-A531-E128BB737366Q52629217-2011DA5E-F543-4DF0-8372-4C8007F10E07
P2860
Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Alteration of serum and tumora ...... in patients with brain tumors.
@en
Alteration of serum and tumoral neural cell adhesion molecule
@nl
type
label
Alteration of serum and tumora ...... in patients with brain tumors.
@en
Alteration of serum and tumoral neural cell adhesion molecule
@nl
prefLabel
Alteration of serum and tumora ...... in patients with brain tumors.
@en
Alteration of serum and tumoral neural cell adhesion molecule
@nl
P2093
P1476
Alteration of serum and tumora ...... in patients with brain tumors.
@en
P2093
Elisa Bal de Kier Joffé
José Lastiri
Laura Todaro
Lydia Puricelli
M Guadalupe Pallotta
Mirta Varela
Paola Campodónico
Silvia Christiansen
P2888
P304
P356
10.1007/S11060-006-9312-0
P577
2007-01-10T00:00:00Z
P6179
1005881515